Department of Pathology News

Dr. Brian Scharf: Netting Success in Science

Friday, March 08, 2013

Winning a pro tennis match requires the same approach it takes to excel in science.

"They both take non-stop focus," said Dr. Brian Scharf, a pathology postdoctoral research fellow in the laboratory of Dr. Laura Santambrogio, and a former professional tennis player.

Though he traded a career on the courts for a bench in a laboratory, after only one year as a fellow, his hard work has paid off.

On November 13, 2012, Dr. Scharf was among three Einstein postdoctoral fellows selected annually to receive the prestigious Dennis Shields Prize for Outstanding Research.

For the pathology researcher, the $5,000 prize - awarded in memory of the internationally recognized cellular biologist who died in 2008 - was "icing on the cake." The award came on the heels of another milestone in his still young career: being first author on a published paper that was based on three years of research to characterize how the body's immune system responds to exposure to biomaterials, such as stents and implants.

The paper, titled "Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris," appeared in the March 2012 issue of Nature Communications. "It was the first article describing the role of Annexin A2 in repairing membrane damage," explained Dr. Scharf.

Impressed by his specialized skill set, Dr Santambrogio, professor of pathology and of microbiology & immunology, hired Dr. Scharf in 2008 through a two-year neuropathology training grant.

"Brian has a unique expertise in electron microscopy (EM), and he developed a new EM imaging technique in the laboratory that has been utilized by other postdocs," she said. "I'm obviously very proud."

Dr. Scharf receiving his prize from Einstein Dean Allen M. Spiegel, M.D.Dr. Scharf gained his experience in electron microscopy at St. John's University, in Queens, where he received his Ph.D. in environmental toxicology. Working under the guidance of professor Louis Trombetta, he examined the toxicity and bioaccumulation of a widely marketed copper-based wood preservative copper dimethyldithiocarbamate (CDDC).

"CDDC was allowed to be put up for sale without testing to see how fast it leeched out," Dr. Scharf said, noting the preservative was readily found in park benches, playgrounds, and porch decks, among other products.

Since there were no prior published toxicological studies of CDDC, a key success in this work was delineating its toxicity and its mechanism of action in multiple organ systems by using a series of biochemical, analytical, and ultrastructural techniques. The findings led to two first-author opportunities for the fledgling researcher and three presentations at annual Society of Toxicology conferences.

"My training as a toxicologist - learning to investigate, interpret, and communicate the nature of toxic effects - helped me on my initial project at Einstein," said Dr Scharf.

He studied the molecular basis of the immune response to particles that result from the wearing down of implanted devices and related ailments caused by this process, which represent a major complication of hip and knee replacements. His current projects include investigating immunological reactions of implanted devices and the biochemical analysis of structural proteins in aging cartilage.

As an athlete, Dr. Scharf knows first-hand how important it is to be able to move with ease. Growing up in Yonkers, Brian and his fraternal twin brother, Erik, played tennis and were attracted to science.

Scharf’s twin brother, Erik, with tennis champion Roger Federer

Scharf’s twin brother, Erik, with tennis champion Roger Federer"Erik was a highly competitive and accomplished gymnast, whereas the same could be said about my running prowess. We decided at the age of 14 to dedicate our focus solely on tennis," said Dr. Scharf.

When it came time for college, he turned down full academic scholarships from West Point and Cornell - and a partial academic scholarship from Columbia - for the full athletic scholarship at St. John's.

Meanwhile, Erik turned down athletic scholarships from Duke, UCLA, and Pepperdine, among others, and followed his brother to Queens, where both played competitive tennis.

In 2002, Dr. Scharf played for one year on the pro tennis circuit, but ultimately traded the grueling - and surprisingly unglamorous lifestyle - for the rigors of science.

"It's a really tough grind; fans don't see all the cutthroat stuff going on behind the scenes," he said, of life on the court.

Meanwhile, Erik, a high performance tennis coach at the John McEnroe Tennis Academy, and an exercise physiologist, went on to play pro tennis for seven years. He had several wins over players ranked in the top 200. He also was Roger Federer's practice partner for the 2008 U.S. Open, in which Federer defeated Andy Murray in the finals that year.

These days, when Dr. Scharf's not in the lab, the "weekend warrior" spends time running or hitting a tennis ball with his twin. "We always joke we have a lifetime practice partner," he said. The two live together in Yonkers.

Looking forward, he hopes to work in government or remain in academia, but is sure to continue his career in science. "It's a field in which you can ask a lot of questions and try to find the answers," he said. "That's the thrill of it."



Posted on: Wednesday, March 06, 2013


Photo Gallery


Recent News 

ZhuHalmos-microscope Teaming Up to Bring Life-Saving Immunotherapy to Cancer Patients Montefiore’s IHC Laboratory and Clinical Oncology Team Up to Bring PD-L1 Testing for Cancer Immunotherapy In-House

Fooksman Visualizing the Immune Response Einstein Researchers Uncover Early Events in Severe Malaria Via Real-Time Video

 

MayaJoining Forces to Validate a Novel Biomarker for Breast Cancer Metastasis. In December 2016, Joseph Sparano, MD, associate chair of medical oncology at the Montefiore Einstein Center for Cancer Care, presented an invited paper at the 39th San Antonio Breast Cancer Symposium in San Antonio, TX. Dr. Sparano reported on a study he led to clinically validate MetaSite (MS), a novel biomarker for metastasis in breast cancer. Joining him were two of his coauthors, Joan Jones, MD, and Maja Oktay, MD,PhD—both members of the Montefiore/Einstein Department of Pathology and Einstein’s Department of Anatomy & Structural Biology.

 

COMMENTARIES IN THE NEWS

Michael Prystowsky Michael Prystowsky, MD, PhD, “The People Have Spoken,” Archives of Pathology, February 2017.read the full article 

 

 

Michael PrystowskyDr. Prystowsky is also featured “An Ocean Apart,” a Q & A with leading British and American leaders in the field, on the role of pathology and pathologists. The Pathologist, January 2017.read the full article  

 

James PullmanJames Pullman, MD, PhD, and Jonathan Nylk, PhD, “Finely Tuned Microscopy,” The Pathologist, December 2016. read the full article 


 

RECENT GRANTS

louis-weissLouis Weiss, MD, MPH, was awarded a $2.1 million, five-year grant by the National Institute of Allergy and Infectious Diseases (NIAID) to continue his efforts to understand how microsporidia—a type of single-celled parasite--infects host cells via a unique invading structure called the polar tube. read more 
 
DavidFooksmanDavid Fooksman, PhD, and Gregoire Lauvau, PhD, received a two-year $250,000 R21 grant from the NIAID to continue their groundbreaking use of in vivo video to shed light on the type 1 interferon pathway, an inflammatory signal that appears to play a pivotal role in severe malaria. (For details, see in Published Research and Cross-Campus Collaborations.)

 

FernandoFernando Macian-Juan, MD, PhD, has received a five-year, $2 million grant from the NIAID to study how chaperone-mediated autophagy (CMA) in T cells regulates the cells’ function. CMA is a degradation system that cells use to break down and recycle their proteins.read more  

 

RachelRachel Hazan, PhD, has received a one-year, $300,000 grant renewal from the Avon Foundation to continue leading a study on the role of cell cycle inhibitor P21 in triple-negative breast cancer, with a focus on metastatic disease. Her project collaborators are Susan Fineberg, MD, and Joseph Sparano, MD.

Research

Experimental pathology aims to define disease in terms of fundamental molecular and cellular processes. Research in our Department is focused on critical issues in multiple disease classes. Areas of focus include 

Research in each of these areas is highly interactive, and the Department strives for a collegial atmosphere in which collaborations can flourish. This effort is conducted through a variety of department-level activities, including regular meetings to discuss work in progress and a departmental retreat at which students, postdoctoral fellows, residents and faculty all have opportunity to present and discuss their research.

Research Funding Program

The Department of Pathology has established a research funding program to encourage residents and fellows to participate in clinical pilot research projects. Up to $2,000 will be awarded per research project, for projects of up to two years in duration.

Research Faculty

Amanda Beck, DVM 

Geoffrey Childs, PhD 

Joan W. Berman, PhD 

Mahalia Desruisseaux, MD, PhD 

Amy Fox, MD  

David Fooksman, PhD  

Rachel Hazan, PhD 

Lawrence Herbst, DVM, PhD 

Huan Huang, MD 

Sunhee C. Lee, MD  

Fernando Macian, MD, PhD 

Maja Oktay, MD, PhD 

Harry Ostrer, MD 

Thomas J. Ow, MD 

Michael B. Prystowsky, MD, PhD 

Moshe Sadofsky, MD, PhD 

Laura Santambrogio, MD, PhD 

Bridget Shafit-Zagardo, PhD 

Herbert Tanowitz, MD 

Louis Weiss, MD 

 
 

AWARDS, HONORS & APPOINTMENTS

FernandoFernando Macian-Juan, MD, PhD, has been granted tenure in the Department of Pathology. Dr. Macian-Juan is a Professor of Pathology. The Macian-Juan laboratory studies the mechanisms that regulate the induction of T cell tolerance and exhaustion; reversal of tumor-induced T cell tolerance as an immunotherapeutic approach; autophagy and T cell function; and aging in the T cell compartment.

 

 

lauraLaura Santambrogio, MD, PhD, has been awarded tenure in the Department of Pathology. Dr. Santambrogio is a Professor of Pathology, of Microbiology & Immunology and of Orthopaedic Surgery. The Santambrogio laboratory investigates antigen processing and MHC class II presentation pathways; pathogenesis of autoimmune response to self antigens; analysis of the lymph formation and lymphatic transport.

 

 

mahaliaMahalia S. Desruisseaux, MD, has been named an Associate Professor of Pathology at Einstein. She also holds the title of Associate Professor of Medicine (Infectious Diseases). Dr. Desruisseaux’s research focus is cerebral malaria: mechanisms of longterm cognitive dysfunction; regulation and activation of vasoactive mediators; and on modulators of blood-brain barrier impairment, and of neuronal and glial cell dysfunction.

Wendy Szymczak, PhD, has been appointed Associate Director of the Clinical Microbiology Laboratory at Montefiore. Dr. Szymczak formerly served as assistant to Laboratory Director Michael Levi, PhD. She also holds the title of Assistant Professor of Pathology at Einstein. Prior to joining Montefiore, Dr. Szymczak completed a post-doctoral research fellowship at Einstein in 2013. She earned her doctorate in molecular genetics, biochemistry & microbiology from the University of Cincinnati College of Medicine in 2010.

Emelia Cortez, Phlebotomy Laboratory manager, and her team, received a certificate of RESPECT in January for their outstanding efforts to ensure that patients in the Phlebotomy Unit at Montefiore’s Greene Medical Arts Pavilion received excellent care despite the challenges of a particularly stressful day. The honor, bestowed on the recommendation of grateful patients, recognizes service that “exemplifies the behaviors of the Montefiore Standards of Respect.”
 

RECENTLY PUBLISHED RESEARCH

 
Over the past year, research studies by Pathology Department faculty members have been published in prestigious, peer-reviewed scientific journals.

View a sampling of these articles here. 
 

TRAINEE SPOTLIGHT

  Gloria Ramos-Rivera, MD, chief resident of the Anatomic and Clinical Pathology Program at Montefiore, has been awarded the College of American Pathologists’s Ventana Fellowship. Funded by Ventana Medical Systems, the $5,000 grant will allow Dr. Ramos Rivera to participate in an advanced elective in translational diagnostics. She will travel to Tucson, AZ, in June, for the four-week training. Read more. 
 
 Decoding the Mysteries of a Lethal Parasite
Tatsuki Sugi, DVM, PhD, a postdoctoral researcher in the laboratory of Dr. Louis Weiss, is shedding light on the survival mechanism of Toxoplasma gondii. Read more. 
 
Exploring Low-Intensity Focused Ultrasound’s Potential as Cancer Immunotherapy
Karin Skalina, a predoctoral fellow in the laboratory of Dr. Chandan Guha, is investigating a new application of ultrasound as a non-invasive approach to cancer immunotherapy. Read more. 

Women’s March 2017: Montefiore Pathology Resident Stands Up for Social Justice
Elizabeth Richards, MD, describes her experience as a participant in the Women’s March in Washington, DC, and in a follow-up event in New York City. Read more. 

NEW FACES

We welcome Fabiane Matos dos Santos, PhD, a Visiting Scientist from the Federal University of Espirito Santo (FUES) in Brazil, and Sangeetha Thangaswamy, PhD,  from the Satara Univerity School of Chemical and Biotechnology in India.

Read about Drs. Matos dos Santos and Thangaswamy, and see the roster of our new Pathology residents here. 

 
Click here to log in